NTRK gene rearrangements are highly enriched in MLH1/PMS2 deficient, BRAF wild-type colorectal carcinomas—a study of 4569 cases-Reference-Cited by-同舟云学术

NTRK gene rearrangements are highly enriched in MLH1/PMS2 deficient, BRAF wild-type colorectal carcinomas—a study of 4569 cases

Published:2019-12-02 Issue:5 Volume:33 Page:924-932
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Chou Angela,Fraser Tamara,Ahadi Mahsa^ORCID,Fuchs Talia^ORCID,Sioson Loretta,Clarkson Adele,Sheen Amy,Singh Nisha,Corless Christopher L.,Gill Anthony J.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/s41379-019-0417-3.pdf

Reference30 articles.

1. Penault-Llorca F, Rudzinski ER, Sepulveda AR. Testing algorithm for identification of patients with TRK fusion cancer. J Clin Pathol. 2019;72:460–7.

2. Cocco E, Scaltriti M, Drilon A. NTRK fusion-positive cancers and TRK inhibitor therapy. Nat Rev Clin Oncol. 2018;15:731–47.

3. Zaborowski M, Gill AJ. Is secretory breast carcinoma underdiagnosed? In the era of targeted therapy should there be a low threshold to screen for NTRK immunohistochemistry in triple negative breast cancers? Pathology. 2019;51:653–5.

4. Solomon JP, Linkov I, Rosado A, Mullaney K, Rosen EY, Frozina D, et al. NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls. Mod Pathol. 2019. https://doi.org/10.1038/s41379-019-0324-7.

5. Vaishnavi A, Le AT, Doebele RC. TRKing down an old oncogene in a new era of targeted therapy. Cancer Discov. 2015;5:25–34.

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High prevalence of NTRK fusions in sporadic dMMR/MSI mCRC RAS/RAF wild-type: an opportunity for a post-immune checkpoint inhibitors progression rescue strategy;ESMO Gastrointestinal Oncology;2024-09

2. Neurotrophic tyrosine receptor kinase gene fusions in adult and pediatric patients with solid tumors: a clinicogenomic biobank and record linkage study of expression frequency and patient characteristics from Finland;Acta Oncologica;2024-07-05

3. Emerging targeted therapies and strategies to overcome resistance in biliary tract cancers;Critical Reviews in Oncology/Hematology;2024-07

4. Molecular Approach to Colorectal Carcinoma;Clinics in Laboratory Medicine;2024-06

5. Elaboration of NTRK-rearranged colorectal cancer: Integration of immunoreactivity pattern, cytogenetic identity, and rearrangement variant;Digestive and Liver Disease;2023-12